Systems medicine advances in interstitial lung disease

Flavia R. Greiffo, Oliver Eickelberg, Isis E. Fernandez

Source: Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017
Journal Issue: September
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Flavia R. Greiffo, Oliver Eickelberg, Isis E. Fernandez. Systems medicine advances in interstitial lung disease. Eur Respir Rev, 26 (145) 170021; 10.1183/16000617.0021-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systems medicine of COPD
Source: International Congress 2017 – Towards personalised medicine for airways diseases: Deep phenotyping using omics approaches will revolutionise future treatment strategies
Year: 2017


Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



Translational immunology in genetic lung disease: advances in cystic fibrosis and Alpha-1 anti-trypsin deficiency
Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease
Year: 2014



Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018



The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019



Contemporary challenges for specialist nursing in interstitial lung disease
Source: Breathe, 14 (1) 36; 10.1183/20734735.014917
Year: 2018



Advances in interstitial lung diseases
Source: Annual Congress 2011 - Clinical Year in Review I
Year: 2011


Systems medicine in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010


Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Advanced cell culture techniques and personalised medicine for cystic fibrosis
Source: International Congress 2015 – Respiratory research in the Netherlands
Year: 2015



Molecular pathology and precision medicine for lung cancer
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017


Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021

Access for REGISTERED non-members

Year: 2021

Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21
Year: 2007

Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021